Valued at USD 5.03 billion in 2024, the sleep apnea devices market is projected to reach USD 5.36 billion in 2025 and USD 9.57 billion by 2034, growing at a CAGR of 6.0% during the forecast period 2025–2034, according to Polaris Market Research. The report identifies the growing use of telemedicine, artificial intelligence, and mobile health in sleep products as a source of lucrative opportunities for market participants through the forecast period.
Sleep apnea is a critical sleeping ailment in which breathing repeatedly stops and starts. Rising awareness and technological advances that enable effective diagnosis and treatment are key growth factors. According to a World Health Organization report, approximately 100 million people are affected by sleep apnea worldwide, and around 42 million people in the US are affected by sleep-disordered breathing, figures the report expects to increase in the coming decade.
Diagnostic Devices and Home Sleep Testing Advance
The market covers diagnostic devices such as polysomnography devices, respiratory polygraphs, pulse oximeters, and actigraphy devices, alongside therapeutic categories. Recent regulatory clearances show where innovation is heading, particularly in home sleep testing.
In May 2025, Wesper received FDA clearance for its home sleep testing kit, which directly measures airflow and respiratory effort without cannulas, improving comfort and the accuracy of detecting central and obstructive sleep events. In February 2025, Huxley Medical announced FDA clearance for its SANSA home sleep apnea test to enable cellular data transmission, removing reliance on Bluetooth or smartphone applications, reducing test failures, and simplifying the diagnostic workflow.
Browse Insights:
https://www.polarismarketresearch.com/industry-analysis/sleep-apnea-devices-market
AI Impact on Sleep Apnea Devices Market Performance
The report outlines several ways AI is influencing the market. It enhances diagnostic accuracy by analyzing large volumes of sleep data in real time, enables personalized treatment by monitoring patient response, and supports early diagnosis and prediction of sleep disorders for earlier intervention.
AI-based algorithms also improve CPAP machines by providing more intelligent pressure control, and incorporating AI into mobile health apps enables continuous monitoring and stronger patient engagement. In February 2024, the FDA approved EnsoData’s Ensosleep, an AI algorithm-based tool used in diagnosing sleep disorders such as sleep apnea. Together, telemedicine, AI, and mobile health are redefining how devices are designed and delivered.
Investment and Innovation Drive Patient Compliance
Leading medical device manufacturers are investing significantly in user-friendly, comfortable sleep apnea products, improving patient compliance and therapeutic outcomes. In May 2024, Novaresp Technologies raised USD 3 million to support clinical trials of its cMAP Positive Airway Pressure software. Funding for portable and home-based equipment is also encouraging adoption, which matters for CPAP machines and related therapy products.
In 2024, the therapeutic devices category held an 82.0% revenue share and home care settings accounted for 62% of the market, showing how far the market has shifted toward patient-friendly, at-home solutions.
Regional and Competitive Outlook
North America dominated the market sleep apnea devices. with a 50.2% share in 2024, supported by changing lifestyles, respiratory disease prevalence, favorable government initiatives, and strong supply and distribution networks. Asia Pacific is projected to register the highest CAGR of 6.8% from 2025 to 2034, driven by a growing geriatric population, lifestyle-related conditions, and increased funding for easy and early diagnosis.
Leading vendors include Curative Medical, Inc.; ResMed; React Health; Somnetics International, Inc.; Respironics (a subsidiary of Koninklijke Philips N.V.); Fisher & Paykel Healthcare Limited; Natus Medical Incorporated; Itamar Medical Ltd.; Nihon Kohden Corporation; SOMNOmedics GmbH; Compumedics; and BMC Medical Co., Ltd. These companies are focusing on research and development and entering developing regions, and the report stresses that user-friendly, portable solutions are essential for competing.
More Trending Latest Reports By Polaris Market Research:
feed-mycotoxin-detoxifiers-market
earth-observation-small-satellite-market